Literature DB >> 34649489

Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives.

Reecha Madaan1, Rajeev K Singla2,3, Suresh Kumar4, Ankit Kumar Dubey5, Dinesh Kumar6, Pooja Sharma4,7, Rajni Bala1, Shailja Singla3, Bairong Shen2.   

Abstract

Bergenin, 4-O-methyl gallic acid glucoside, is a bioactive compound in various plants belonging to different families. The present work compiles scattered information on pharmacology, structure-activity relationship and nanotechnological aspects of bergenin, collected from various electronic databases such as Sci Finder, PubMed, Google Scholar, etc. Bergenin has been reported to exhibit hepatoprotective, anti-inflammatory, anticancer, neuroprotective, antiviral, and antimicrobial activities. Molecular docking studies have shown that isocoumarin pharmacophore of bergenin is essential for its bioactivities. Bergenin holds a great potential to be used as a lead molecule and also as a therapeutic agent for the development of more efficacious and safer semisynthetic derivatives. Nanotechnological concepts can be employed to overcome the poor bioavailability of bergenin. Finally, it is concluded that bergenin can emerge as clinically potential medicine in modern therapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Anti-inflammatory; Anticancer; Bergenin; Hepatoprotective; Molecular docking; Nanotechnology

Mesh:

Substances:

Year:  2022        PMID: 34649489     DOI: 10.2174/1568026621666211015092654

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

Review 1.  Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.

Authors:  Rajeev K Singla; Sahar Behzad; Johra Khan; Christos Tsagkaris; Rupesh K Gautam; Rajat Goyal; Hitesh Chopra; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

Review 2.  Translational Informatics for Natural Products as Antidepressant Agents.

Authors:  Rajeev K Singla; Shikha Joon; Li Shen; Bairong Shen
Journal:  Front Cell Dev Biol       Date:  2022-01-20

3.  Bergenin ameliorates cognitive deficits and neuropathological alterations in sodium azide-induced experimental dementia.

Authors:  Rajeev K Singla; Konika Dhonchak; Rupinder K Sodhi; M Arockia Babu; Jitender Madan; Reecha Madaan; Suresh Kumar; Rohit Sharma; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

4.  Editorial: Exploration of Natural Product Leads for Multitarget-Based Treatment of Cancer-Computational to Experimental Journey.

Authors:  Rajeev K Singla; Marcus T Scotti; Supratik Kar
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.